AdaptHealth Corp. (AHCO) – What Are Analysts Thinking About This Stock?

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $10.14.

A number of analysts have commented on the stock. Truist Financial dropped their price target on shares of AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a research report on Wednesday, August 5th. Royal Bank Of Canada cut their target price on AdaptHealth from $15.00 to $8.00 and set an “outperform” rating for the company in a research report on Thursday, August 6th. Robert W. Baird lowered their price target on AdaptHealth from $10.00 to $9.00 and set an “outperform” rating on the stock in a research report on Thursday, September 17th. Jefferies Financial Group upgraded AdaptHealth from a “hold” rating to a “buy” rating and upped their price objective for the company from $11.00 to $13.00 in a report on Tuesday, July 21st. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a research report on Wednesday, August 19th.

Insider Activity

In other AdaptHealth news, Director Kenneth Samet bought 23,500 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The shares were acquired at an average cost of $6.38 per share, for a total transaction of $149,930.00. Following the acquisition, the director directly owned 48,569 shares of the company’s stock, valued at $309,870.22. This trade represents a 93.74% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 1.95% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP grew its position in AdaptHealth by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock worth $82,353,000 after purchasing an additional 518,274 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of AdaptHealth by 25.1% in the first quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock valued at $33,133,000 after purchasing an additional 558,357 shares in the last quarter. Kennedy Capital Management LLC boosted its position in shares of AdaptHealth by 15.2% in the fourth quarter. Kennedy Capital Management LLC now owns 2,408,038 shares of the company’s stock worth $23,984,000 after buying an additional 317,900 shares during the period. Lazard Asset Management LLC grew its holdings in shares of AdaptHealth by 35.0% during the first quarter. Lazard Asset Management LLC now owns 1,669,454 shares of the company’s stock valued at $19,867,000 after buying an additional 432,664 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in AdaptHealth by 87.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 847,085 shares of the company’s stock valued at $10,080,000 after buying an additional 395,668 shares during the period. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Trading Up 1.3%

Shares of AHCO stock opened at $6.14 on Thursday. AdaptHealth has a 1 year low of $5.21 and a 1 year high of $13.43. The firm has a market capitalization of $837.13 million, a PE ratio of -3.59 and a beta of 1.42. The stock has a fifty day moving average of $5.83 and a two-hundred day moving average of $9.17. The company has a debt-to-equity ratio of 1.37, a quick ratio of 0.98 and a current ratio of 1.12.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings results on Tuesday, August 4th. The company reported ($0.99) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($1.16). AdaptHealth had a negative net margin of 7.07% and a positive return on equity of 3.36%. The business had revenue of $740.31 million for the quarter, compared to analyst estimates of $846.77 million. During the same period last year, the business posted $0.10 earnings per share. AdaptHealth’s revenue for the quarter was down 7.5% on a year-over-year basis.

AdaptHealth Company Profile

AdaptHealth Corp. is a provider of home healthcare equipment, medical supplies and related services in the United States. The company helps patients manage medical conditions outside traditional healthcare settings by delivering equipment to their homes and providing education, setup and ongoing support.

Its offerings include respiratory equipment such as oxygen systems and ventilators, sleep therapy products including continuous positive airway pressure (CPAP) devices, diabetes supplies, mobility and assistive equipment, and other durable medical equipment.